Kaken Pharmaceutical (4521.TSE) Q4 2023 Earnings

6FebConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
72.2
72.53
72.87
73.2

Details

Expected EPS
N/A
Actual EPS
72.19866168864
Surprise EPS
72.2
Surprise Percent
+∞%

Description

Kaken Pharmaceutical (4521.TSE) has reported earnings of 72.19866168864 per share for Q4 2023.

0 Comments

Share your thoughts